Clinical Trials On-Line - Physican: Thehang Luu

The following is a list of available studies directed by Thehang Luu, MD

Search results: 4 Clinical trial(s) found (Page 1 of 1 )

Click here to generate a printer-friendly view

08103

P.I.:

Thehang Luu, MD

Title:

Phase I/II Vinorelbine and Sorafenib as Salvage Therapy in Metastatic Breast Cancer

Click here for	Brief Eligibility Criteria
	Full Eligibility Criteria

08008

P.I.:

Thehang Luu, MD

Title:

A Phase I/II Study of HKI-272 in Combination with Vinorelbine in Subjects with Solid Tumors and Metastatic Breast Cancer

Click here for	Brief Eligibility Criteria
	Full Eligibility Criteria

06167

P.I.:

Thehang Luu, MD

Title:

CTSU/ECOG: Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial

Click here for	Brief Eligibility Criteria
	Full Eligibility Criteria

05138

P.I.:

Thehang Luu, MD

Title:

PHI-53 NCI#7251: A Phase I Trial of PXD101 in Combination with 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies

Click here for

Full Eligibility Criteria

City of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.

City of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.

We subscribe to the HONcode of the Healthcare on the Net Foundation.

City of Hope

Page Title

Global Navigation